Palisade Bio
PALI
9 hedge funds and large institutions have $347K invested in Palisade Bio in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 0 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
17% more capital invested
Capital invested by funds: $298K → $347K (+$49.7K)
13% more funds holding
Funds holding: 8 → 9 (+1)
1.29% more ownership
Funds ownership: 7% → 8.29% (+1.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$93K |
| 2 |
JP Morgan Chase
New York
|
+$31.6K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.31K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$15 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$4.56K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $185K | +$93K | +24,142 | +87% |
|
|
MG
2
Marex Group
London,
| $127K | – | – | – |
|
|
3
JP Morgan Chase
New York
| $29.1K | +$31.6K | +8,200 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $5.67K | +$3.31K | +859 | +116% |
|
5
Morgan Stanley
New York
| $497 | – | – | – |
|
|
FDCDDQ
6
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $355 | – | – | – |
|
|
7
UBS Group
Zurich,
Switzerland
| $110 | -$4.56K | -1,185 | -97% |
|
8
Wells Fargo
San Francisco,
California
| $75 | – | – | – |
|
|
9
Bank of America
Charlotte,
North Carolina
| $32 | +$15 | +4 | +80% |
|
PALI Hedge Fund Activity: Q3 2024 in Review
9 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q3 2024, worth a combined $347K — up 17% from $298K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new PALI positions and 0 closed out — a net gain of 1 holder — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Armistice Capital, adding an estimated $93K. The largest seller was UBS Group, cutting an estimated $4.56K.
- 9 institutional investors held Palisade Bio (PALI) as of Q3 2024, up from 8 in Q2 2024.
- Funds reported $347K of Palisade Bio stock for Q3 2024, up 17% quarter-over-quarter.
- 1 fund opened new Palisade Bio positions in Q3 2024 and 0 closed out, a net change of +1 holder.
- The largest Palisade Bio buyer in Q3 2024 was Armistice Capital, an estimated $93K added.
- The largest Palisade Bio seller in Q3 2024 was UBS Group, an estimated $4.56K sold.
Based on aggregated 13F filings for Q3 2024.